Can prolonged intestinal transit reduce elimination of conjugated xenobiotics?

Biliary handling is an important elimination pathway for many drug and environmental xenobiotic conjugates, but the proposed effect of slow intestinal transit on whole-body elimination remains mechanistically credible rather than directly established in humans.

Established transport and recycling biology

• Hepatocyte canalicular MRP2/ABCC2 exports glucuronide, sulfate, and glutathione conjugates into bile. In MRP2-deficient rat livers, biliary moxifloxacin-glucuronide output was only 0.027% of wild-type output; reductions have also been reported for indomethacin and diclofenac glucuronides.
• Human data are consistent with this pathway: sorafenib glucuronide is substantially eliminated and inferred to undergo MRP2-mediated biliary secretion, while cabotegravir glucuronide was the predominant metabolite detected in human bile.
• Biliary conjugates enter the intestinal lumen and can contribute to fecal drug-related recovery. Stool, however, may contain intact conjugate, microbially transformed products, unabsorbed oral drug, or material secreted directly by the intestine; fecal recovery alone does not quantify biliary clearance.

Mechanistic implications of prolonged transit

• Gut microbial β-glucuronidases can hydrolyze biliary glucuronides, regenerating parent drug or another aglycone. When the liberated compound is intestinally permeable, it may be reabsorbed, establishing enterohepatic recycling.
• A longer intestinal residence time could provide more opportunity for this hydrolysis and reabsorption. β-Glucuronidase activity varies substantially by intestinal region and between individuals, making any effect dependent on the compound, microbiome, biliary delivery, and intestinal permeability.
• Recycling can prolong systemic exposure and reduce apparent systemic clearance for some hepatically eliminated agents. Reabsorbed drug may nevertheless be reconjugated and ultimately excreted, so a reduced rate of elimination does not necessarily mean reduced final total-body elimination.

Bottom line

• The biliary excretion and microbial deconjugation–reabsorption pathway is well supported; the specific assertion that prolonged transit measurably increases recycling and reduces net elimination is plausible but compound-specific and not directly demonstrated by human transit-controlled pharmacokinetic or mass-balance studies.